Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
$0.52
+3.4%
$0.60
$0.40
$2.57
$10.85M0.15223,511 shs485,371 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
0.00%-19.69%-21.56%-11.93%-79.34%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/AN/AN/AN/A
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
0.1862 of 5 stars
0.01.00.00.03.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00
N/AN/AN/A
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
$6.64M1.69N/AN/A$0.17 per share3.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
-$1.14MN/A0.00N/AN/A-36.27%-32.76%6/26/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
N/A
6.24
6.24

Institutional Ownership

CompanyInstitutional Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
5.66%

Insider Ownership

CompanyInsider Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable
BP Prudhoe Bay Royalty Trust stock logo
BPT
BP Prudhoe Bay Royalty Trust
2,02021.40 millionN/AOptionable

Recent News About These Companies

BP Prudhoe Bay Initiates Asset Sale Process
BP Prudhoe Bay Faces Delisting and Termination
BP Prudhoe Bay Royalty Trust

Media Sentiment Over Time

Top Headlines

View All Headlines
BELLUS Health stock logo

BELLUS Health NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

BP Prudhoe Bay Royalty Trust stock logo

BP Prudhoe Bay Royalty Trust NYSE:BPT

$0.52 +0.02 (+3.37%)
Closing price 03:57 PM Eastern
Extended Trading
$0.52 +0.00 (+0.19%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. It is involved in holding overriding royalty interest in the Prudhoe Bay oil field located on the North Slope of Alaska. The Prudhoe Bay field extends approximately 12 miles by 27 miles and contains approximately 150,000 gross productive acres. BP Prudhoe Bay Royalty Trust was incorporated in 1989 and is based in Houston, Texas.